Skip to main content

Find Clinical Trials

Home
Conditions
Adjuvant Immunotherapy

Clinical trial condition

Adjuvant Immunotherapy

Explore clinical trials studying Adjuvant Immunotherapy. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Adjuvant Immunotherapy trial results

Recruiting

Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

NCT07120698

Conditions: Adjuvant Immunotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

The third people's hospital of chengdu Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

NCT06977828

Conditions: Adjuvant Immunotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Completed

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

NCT06298123

Conditions: Adenocarcinoma, Adjuvant Immunotherapy, Carcinoma, +11 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details